Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2024 Results Presentation

Ginkgo Bioworks (NYSE: DNA) has scheduled its Q4 and full year 2024 financial results presentation for Tuesday, February 25, 2025, at 5:30 p.m. ET.

Rhea-AI Summary

Ginkgo Bioworks (NYSE: DNA) has scheduled its Q4 and full year 2024 financial results presentation for Tuesday, February 25, 2025, at 5:30 p.m. ET. The presentation will include a business performance review and Q&A session.

Investors can access the presentation and webcast through Ginkgo's investor relations website, with a replay option available afterward. Questions can be submitted in advance via X (using #GinkgoResults) or email to investors@ginkgobioworks.com.

Argus Session date unavailable

-6.52% session move Open Argus

Details

News Market Reaction – DNA

The recorded move for DNA in the trading session of this news was -6.52%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Presentation and Q&A session scheduled for post-market on Tuesday, February 25, 2025

BOSTON, Feb. 18, 2025 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) ("Ginkgo"), which is building the leading platform for cell programming and biosecurity, today announced that it plans to host a presentation and Q&A session reviewing business performance for the fourth quarter and full year ended December 31, 2024, on Tuesday, February 25, 2025, beginning at 5:30 p.m. ET.

The presentation details and webcast link will be available on Ginkgo's investor relations website at https://investors.ginkgobioworks.com, and a replay will be made available.

To ask a question ahead of the presentation, please submit them to @Ginkgo on X (hashtag #GinkgoResults) or by sending an e-mail to investors@ginkgobioworks.com.

About Ginkgo Bioworks

Ginkgo Bioworks is the leading horizontal platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Ginkgo Biosecurity is building and deploying the next-generation infrastructure and technologies that global leaders need to predict, detect, and respond to a wide variety of biological threats.  For more information, visit ginkgobioworks.com and ginkgobiosecurity.com, read our blog, or follow us on social media channels such as X (@Ginkgo and @Ginkgo_Biosec), Instagram (@GinkgoBioworks), Threads (@GinkgoBioworks) or LinkedIn.

Ginkgo Bioworks Contacts:

INVESTOR CONTACT:

investors@ginkgobioworks.com 

MEDIA CONTACT:

press@ginkgobioworks.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/ginkgo-bioworks-announces-date-of-fourth-quarter-and-full-year-2024-results-presentation-302378620.html

SOURCE Ginkgo Bioworks

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Ginkgo Bioworks (DNA) release its Q4 2024 earnings?

Ginkgo Bioworks will release its Q4 and full year 2024 earnings on Tuesday, February 25, 2025, after market close, with a presentation starting at 5:30 p.m. ET.

How can investors access Ginkgo Bioworks' Q4 2024 earnings call?

Investors can access the presentation and webcast through Ginkgo's investor relations website at https://investors.ginkgobioworks.com.

How can investors submit questions for Ginkgo Bioworks' Q4 2024 earnings call?

Investors can submit questions either through X (using #GinkgoResults) or by emailing investors@ginkgobioworks.com.

Will there be a replay available for Ginkgo Bioworks' Q4 2024 earnings presentation?

Yes, a replay of the earnings presentation will be made available on Ginkgo's investor relations website.